SurgePays, Inc. SURG
Advertising · data as of November 13, 2026
SurgePays, Inc. (SURG) is a consumer discretionary company listed in the US with a market value of about $9M. In the twelve months to June 30, 2026 it had revenue of $67M and net income of -$32M, a net margin of -47.9%.
Its overall Stock Analiz score is 0.4 out of 5 (weak). The strongest part is track record (1/5); the weakest is value (0/5).
Key numbers: 5-year revenue growth of 1% a year, a 5-year average ROIC of -49%.
About SurgePays
SurgePays is listed in the US and classified in advertising. Revenue went from $3M in 2015 to $57M in 2025, growth of about 35.0% a year. It was profitable in 2 of the last 10 years in our data. Its share count rose by 62% over three years (dilution for shareholders).
Score: 0.4 / 5
Checks passed
- ROE above 15%
- Stock-based pay below 5% of revenue
Checks not passed
- P/E below 25
- P/E below the industry median
- P/FCF below 20
- Price below intrinsic value (DCF, moderate assumptions)
- PEG below 1.5
- Revenue growth above 10% last year
- 3-year revenue growth above 10% a year
- Profit margin improving
Valuation
Growth and quality
Financials, last 10 years
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $67M | $57M | $61M | $137M | $122M | $51M | $54M | $26M | $15M | $13M | $3M |
| Net income | -$32M | -$36M | -$46M | $21M | -$680763 | -$14M | -$11M | -$8M | -$2M | $3M | -$5M |
| Free cash flow | — | -$21M | -$22M | $10M | $781870 | -$15M | -$4M | -$7M | -$1M | $80802 | -$644877 |
| EPS (diluted) | $-1.53 | $-1.80 | $-2.39 | $1.38 | $-0.05 | $-3.09 | $-5.02 | $-4.50 | $-1.00 | $2.00 | $-5.00 |
| Net margin | -47.9% | -63.3% | -75.1% | 15.0% | -0.6% | -26.5% | -19.7% | -32.8% | -10.1% | 20.6% | -139.5% |
| ROIC | — | — | -172.5% | 44.2% | 3.8% | -71.8% | — | -151.8% | — | — | — |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
Frequently asked questions
Does SurgePays pay a dividend?
Not currently.
Is SurgePays a good stock to buy?
We do not give buy or sell advice. SurgePays scores 0.4 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.